443 related items for PubMed ID: 11897984
1. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
4. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A, Hall I, Spelman R.
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[Abstract] [Full Text] [Related]
5. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
6. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
7. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD, Moore A, Mersmann S, Dissanayake S.
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[Abstract] [Full Text] [Related]
8. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
Malo JL, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet LP.
Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
[Abstract] [Full Text] [Related]
9. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CJ, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005309. PubMed ID: 16235400
[Abstract] [Full Text] [Related]
10. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.
Barnes N, van Noord JA, Brindicci C, Lindemann L, Varoli G, Perpiña M, Guastalla D, Casula D, Patel S, Chanez P, FACTO (Foster® As Complete Treatment Option) Study Group.
Pulm Pharmacol Ther; 2013 Oct 19; 26(5):555-61. PubMed ID: 23524015
[Abstract] [Full Text] [Related]
11. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul 19; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
12. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
Terzano C, Ricci A, Burinschi V, Nekam K, Lahovsky J.
Respir Med; 2003 Feb 19; 97 Suppl B():S35-40. PubMed ID: 12593526
[Abstract] [Full Text] [Related]
13. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CK, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005309. PubMed ID: 16625634
[Abstract] [Full Text] [Related]
14. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul 19; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
15. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
J Allergy Clin Immunol; 2005 Feb 19; 115(2):233-42. PubMed ID: 15696076
[Abstract] [Full Text] [Related]
16. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
Respir Med; 1996 Nov 19; 90(10):609-17. PubMed ID: 8959118
[Abstract] [Full Text] [Related]
17. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar 19; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
18. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
Arerugi; 2007 Jun 19; 56(6):577-86. PubMed ID: 17615501
[Abstract] [Full Text] [Related]
19. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
Ann Allergy Asthma Immunol; 2004 Sep 19; 93(3):253-8. PubMed ID: 15478385
[Abstract] [Full Text] [Related]
20. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
Nathan RA, Nolop KB, Cuss FM, Lorber RR.
Chest; 1997 Jul 19; 112(1):34-9. PubMed ID: 9228354
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
